{
  "report_rows": [
    {
      "kpi": "Adjusted diluted EPS",
      "prediction": "IN-LINE",
      "answer": "pred ~$1.52 vs. cons $1.5115",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$22.00B vs. cons $21.944B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "U.S. local case growth",
      "prediction": "BEAT",
      "answer": "pred ~2.70% vs. cons 2.65%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2027 adjusted EPS",
      "prediction": "BETTER",
      "answer": "guide ~$4.95-$5.05 vs. cons $4.9287",
      "confidence": "LOW"
    },
    {
      "kpi": "FY2027 revenue",
      "prediction": "BETTER",
      "answer": "guide ~$89.0-$90.0B vs. cons $88.465B",
      "confidence": "LOW"
    },
    {
      "kpi": "FY2027 local case growth",
      "prediction": "BETTER",
      "answer": "guide ~2.5% vs. cons 2.17%",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": 1.5,
  "day1_confidence": "LOW",
  "day5_residual_pct": 2.5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH \u2014 FY2027 estimate revisions",
  "day5_confidence": "LOW"
}